Dulaglutide as treatment escalation of SGLT2 in type 2 diabetes: The AWARD-10 trial
This 3rd in a series of 3 Study Briefs summarises the key findings from the AWARD-10 clinical trials, featuring expert advice from Dr Roy Rasalam to help you optimise your practice.
Sign up for free and continue reading
Med CPD offers the widest range of courses and content, all accessible in one place. Click on the Sign up button and start looking after the health of your career.